The pathogenesis of cutaneous squamous cell carcinoma in organ transplant recipients

C A Harwood1, A E Toland2, C M Proby3

  • 1Centre for Cell Biology and Cutaneous Research, Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, U.K.

Insights

Organ transplant recipients face multifactorial risks for skin cancer. Understanding the interplay of UV radiation, immune suppression, medications, viruses, and genetics is key for prevention.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Organ transplantation requires immunosuppression, increasing cancer risk.
  • Keratinocyte carcinoma is a common post-transplant malignancy.
  • Multiple factors contribute to skin cancer development in transplant patients.

Purpose of the Study:

  • To review the multifactorial pathogenesis of keratinocyte carcinoma in organ transplant recipients.
  • To highlight the interplay of risk factors including UV radiation, immune status, medications, viruses, and host genetics.
  • To identify knowledge gaps crucial for developing biomarkers and targeted therapies.

Main Methods:

  • Literature review of evidence on keratinocyte carcinoma pathogenesis post-transplantation.
  • Synthesis of data on carcinogenic and protective effects of various factors.
  • Identification of interdependencies and knowledge gaps.

Main Results:

  • Keratinocyte carcinoma development is influenced by UV radiation, impaired immune surveillance, drug effects, human papillomaviruses, and genetic factors.
  • These factors exhibit complex and synergistic interactions.
  • Significant gaps exist in understanding the relative contributions and interdependencies of these co-factors.

Conclusions:

  • A comprehensive understanding of the interplay between UV radiation, immunosuppression, iatrogenic, viral, and genetic factors is essential for managing post-transplant skin cancers.
  • Further research is needed to elucidate these interactions for improved clinical strategies.
  • Targeted biomarkers and prevention strategies require a clearer understanding of co-factor contributions.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
84.6K
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.1K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.2K
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.8K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
537
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
492